Search result

Phantom 4 RTK/feed/category/dji-mavic-3-pl- Page 162

D-Wave Quantum (QBTS) Stock News Today: CES 2026 Catalyst, Analyst Forecasts, and a Reality Check on Valuation

D-Wave Quantum (QBTS) Stock News Today: CES 2026 Catalyst, Analyst Forecasts, and a Reality Check on Valuation

D-Wave Quantum stock closed at $27.52 on Dec. 24, down 5.5% after a volatile week that saw a surge to $32.10 on news it will showcase commercial quantum tech at CES 2026. The company plans to sponsor CES Foundry in January and hold its Qubits 2026 conference later that month, focusing on technical updates and customer adoption.
Novo Nordisk Stock (NVO): Wegovy Pill FDA Approval, CagriSema Filing, and the 2026 Outlook Investors Are Watching (Dec. 25, 2025)

Novo Nordisk Stock (NVO): Wegovy Pill FDA Approval, CagriSema Filing, and the 2026 Outlook Investors Are Watching (Dec. 25, 2025)

The U.S. FDA approved Novo Nordisk’s Wegovy pill, the first oral GLP-1 drug for chronic weight management, on Dec. 22. Novo Nordisk ADRs closed at $52.56 on Dec. 24, up 1.8% after the news. The company plans a U.S. launch in early January 2026. Trial data showed a mean weight loss of 16.6% for patients adhering to the regimen.
25 diciembre 2025
Rocket Lab Stock (RKLB) Surges Into 2026: Space Force Satellite Deal, Record 2025 Launches, Analyst Forecasts, and Key Risks

Rocket Lab Stock (RKLB) Surges Into 2026: Space Force Satellite Deal, Record 2025 Launches, Analyst Forecasts, and Key Risks

Rocket Lab won a U.S. Space Development Agency contract worth up to $816 million to build 18 missile warning satellites, with launches set for fiscal 2029. The company also ended 2025 with 21 successful Electron launches, hitting a new annual record. U.S. markets are closed for Christmas Day.
Meta Stock After Hours Today (Dec. 25, 2025): WhatsApp AI Antitrust Order, Wall Street Forecasts, and What to Watch Before Friday’s Open

Meta Stock After Hours Today (Dec. 25, 2025): WhatsApp AI Antitrust Order, Wall Street Forecasts, and What to Watch Before Friday’s Open

U.S. stock markets were closed Dec. 25 for Christmas, leaving Meta’s last after-hours price at $666.31, down 0.19% from the Dec. 24 close. Italy’s antitrust authority ordered Meta to suspend WhatsApp terms that could block rival AI chatbots, citing possible abuse of dominance. Meta said it will appeal. The next trading session is Friday, Dec. 26, with thin holiday volumes expected.
25 diciembre 2025
US Stock Market Today (Dec. 25, 2025): S&P 500 and Dow End Christmas Eve at Record Highs as 2026 Outlook Turns to AI, Earnings, and Fed Rate Cuts

US Stock Market Today (Dec. 25, 2025): S&P 500 and Dow End Christmas Eve at Record Highs as 2026 Outlook Turns to AI, Earnings, and Fed Rate Cuts

U.S. stock markets are closed Dec. 25 for Christmas after the Dow, S&P 500, and Nasdaq all ended Wednesday at record highs. The S&P 500 is up over 17% for 2025, marking a third straight year of double-digit gains. Trading resumes Friday. The “Santa Claus rally” period began Wednesday and runs through Jan. 5.
25 diciembre 2025
Cloud Computing Stocks Outlook 2026: The Biggest Winners, Risks, and Fresh Analyst Calls as AI Supercharges the Cloud (Dec. 25, 2025)

Cloud Computing Stocks Outlook 2026: The Biggest Winners, Risks, and Fresh Analyst Calls as AI Supercharges the Cloud (Dec. 25, 2025)

Global cloud infrastructure spending reached $102.6 billion in Q3 2025, up 25% from a year earlier, with AWS, Azure, and Google Cloud taking 66% of the market. Tech firms issued $428.3 billion in bonds in 2025 to fund AI and cloud expansion, while credit markets show rising caution. AWS posted 20% revenue growth, Azure 40%, and Google Cloud 36% for the quarter.
Healthcare Stocks Outlook (Dec. 25, 2025): Wegovy Pill Breakthrough, FDA Approvals, and a New Wave of M&A Heading Into 2026

Healthcare Stocks Outlook (Dec. 25, 2025): Wegovy Pill Breakthrough, FDA Approvals, and a New Wave of M&A Heading Into 2026

The FDA approved Novo Nordisk’s oral Wegovy pill for chronic weight management, marking the first U.S. approval of an oral GLP‑1 for obesity. The decision sent biotech shares higher and intensified competition in the obesity drug market. U.S. markets were closed for Christmas. Novo Nordisk plans a U.S. launch in early January 2026.
25 diciembre 2025
Home Depot (HD) News on December 25, 2025: Fiscal 2026 Forecast, Q3 Earnings, Pro Strategy, and the Latest Risk Signals

Home Depot (HD) News on December 25, 2025: Fiscal 2026 Forecast, Q3 Earnings, Pro Strategy, and the Latest Risk Signals

Home Depot stores in the U.S. are closed December 25 for Christmas, with normal operations to resume after the holiday. The company’s latest guidance projects fiscal 2026 sales growth of 2.5% to 4.5% and flat to 2% comparable sales, trailing Wall Street expectations. Executives continue to emphasize a focus on professional customers amid a slow home improvement market.
Cisco Systems (CSCO) News on Dec. 25, 2025: AI Networking Tailwinds, FY2026 Forecasts, and a Critical Email-Security Zero-Day

Cisco Systems (CSCO) News on Dec. 25, 2025: AI Networking Tailwinds, FY2026 Forecasts, and a Critical Email-Security Zero-Day

Cisco raised its FY2026 outlook on strong AI-driven networking demand, reporting solid Q1 results and increased hyperscaler orders. Meanwhile, a critical zero-day vulnerability, CVE-2025-20393, is being actively exploited against Cisco email security appliances, with U.S. agencies requiring urgent mitigation. Cisco became aware of the attack in early December, with incidents traced to a suspected Chinese threat actor.
Merck & Co. (MRK) Enters 2026 in the Spotlight: BMO Upgrade to $130, FDA Fast-Track Vouchers and TrumpRx Pricing Deal Reframe the Post-Keytruda Story

Merck & Co. (MRK) Enters 2026 in the Spotlight: BMO Upgrade to $130, FDA Fast-Track Vouchers and TrumpRx Pricing Deal Reframe the Post-Keytruda Story

Merck shares closed at $106.45 on Dec. 24, capping a six-day rally driven by a BMO Capital Markets upgrade to Outperform and a new $130 price target. Analysts cited confidence in Merck’s pipeline as it prepares for Keytruda’s 2028 loss of exclusivity. Recent gains also follow positive oncology data and a European regulatory milestone for Winrevair. U.S. markets were closed Dec. 25 for Christmas.
25 diciembre 2025
Apple Stock (AAPL) Before the Market Opens Dec. 26, 2025: Latest News, Analyst Forecasts, and Key Catalysts to Watch

Apple Stock (AAPL) Before the Market Opens Dec. 26, 2025: Latest News, Analyst Forecasts, and Key Catalysts to Watch

Apple shares last traded at $273.81 on Dec. 24 ahead of Friday’s full U.S. market session, which follows the Christmas closure. New regulatory actions on the App Store in Brazil, Italy, Japan, and the EU have intensified scrutiny of Apple’s Services business. November data showed foreign-branded phone shipments in China more than doubled year over year, boosting sentiment for iPhone demand.
25 diciembre 2025
UK Stock Market Preview for 26 December 2025: Boxing Day Closure, FTSE 100 Drivers, Sterling Moves, Oil Pressure and the BoE Outlook

UK Stock Market Preview for 26 December 2025: Boxing Day Closure, FTSE 100 Drivers, Sterling Moves, Oil Pressure and the BoE Outlook

The London Stock Exchange will be closed on Friday, 26 December 2025, for Boxing Day. In the last session before the break, the FTSE 100 fell 0.2%. BP agreed to sell a 65% stake in Castrol to Stonepeak for about $6 billion, valuing Castrol at $10.1 billion. UK traders will return after the holiday to a market influenced by global moves and BP’s deal.
Apple Stock (AAPL) Before the Market Opens Dec. 26, 2025: Latest News, iPhone Demand Signals, AI “Siri 2.0” Watchpoints, and Key Risks

Apple Stock (AAPL) Before the Market Opens Dec. 26, 2025: Latest News, iPhone Demand Signals, AI “Siri 2.0” Watchpoints, and Key Risks

U.S. markets are closed Dec. 25 for Christmas, with trading set to resume Dec. 26. Apple last traded at $273.81, about 5% below its Dec. 3 high, and holds a $4.05 trillion market cap. November data from China showed foreign-branded phone shipments, including iPhones, jumped 128.4% year-over-year. Holiday-adjacent sessions often see thin trading and amplified moves.
Procter & Gamble (PG) Stock: CEO Change, January Earnings Date, Tariff Outlook and Analyst Targets to Watch Before the Dec. 26, 2025 Market Open

Procter & Gamble (PG) Stock: CEO Change, January Earnings Date, Tariff Outlook and Analyst Targets to Watch Before the Dec. 26, 2025 Market Open

U.S. stocks reopen Friday, Dec. 26, after the Christmas holiday, with Procter & Gamble last indicated at $144.49 following a 2025 decline of over 13% amid consumer and competition concerns. P&G’s CEO transition to Shailesh Jejurikar takes effect Jan. 1, with Jon Moeller becoming Executive Chairman. The company’s next earnings call is set for Jan. 22, 2026.
26 diciembre 2025
Merck (MRK) Stock: Key News, Analyst Targets, and Catalysts to Know Before the Market Opens Dec. 26, 2025

Merck (MRK) Stock: Key News, Analyst Targets, and Catalysts to Know Before the Market Opens Dec. 26, 2025

U.S. stock markets were closed Dec. 25 for Christmas and will reopen Dec. 26 after an early close Dec. 24. Merck shares last traded near $106.45. The White House named Merck in new drug-pricing agreements announced Dec. 19, with Merck confirming plans for steep discounts on key diabetes drugs. Merck’s next earnings call is scheduled for Feb. 3, 2026.
26 diciembre 2025
1 160 161 162 163 164 176

Stock Market Today

  • Summit Therapeutics Shares Appear Significantly Undervalued Amid Recent Pullback
    February 8, 2026, 1:51 PM EST. Summit Therapeutics (SMMT) stock closed at $14.99 after a recent 3.5% weekly gain but has declined 23.8% over 30 days and 25.5% over the past year. Despite these pullbacks, the company has delivered strong multi-year returns, including a 94.7% five-year gain. Using a Discounted Cash Flow (DCF) model, which estimates future cash flows discounted to present value, Summit appears undervalued by 93.3%, with an intrinsic value estimated at $224.46 per share. The firm reported a $270 million free cash flow loss over the past year but projects substantial cash flow growth by 2030. However, Summit scores only 2 out of 6 on valuation metrics, suggesting caution amid investment risks in the pharmaceutical and biotech sectors.

Latest article

Microsoft stock price heads into Monday: MSFT rebounds, but AI spending nerves stay hot

Precio de las acciones de Microsoft de cara al lunes: MSFT se recupera, pero persisten las preocupaciones por el gasto en IA

8 febrero 2026
Las acciones de Microsoft subieron 1.9% el viernes y cerraron en $401.14, tras caer 5% el jueves por preocupaciones sobre el gasto en IA. Stifel rebajó la calificación de la empresa y redujo su precio objetivo a $392. Los inversores observan el crecimiento de Azure y el impacto de la inversión en IA en los márgenes. Se esperan datos clave de empleo e inflación en EE. UU. la próxima semana.

Popular

Micron stock price slips 4% in early trade as chip rally cools — what’s next for MU

Las acciones de Micron caen un 4% en la apertura mientras se enfría el repunte de los chips: ¿qué sigue para MU?

4 febrero 2026
Las acciones de Micron cayeron 4,2% a $419,44 en el Nasdaq tras una venta masiva en tecnología y la caída de AMD. TrendForce prevé que los precios de DRAM subirán hasta 95% en el primer trimestre, impulsados por la demanda de IA. Analistas advierten de una escasez de chips de memoria sin precedentes. Los inversores esperan la conferencia de Micron el 11 de febrero.
Go toTop